Inosine induces stemness features in CAR-T cells and enhances potency-Reference-Cited by-同舟云学术

Inosine induces stemness features in CAR-T cells and enhances potency

Published:2024-02 Issue:2 Volume:42 Page:266-282.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Klysz Dorota D.,Fowler Carley,Malipatlolla Meena,Stuani Lucille,Freitas Katherine A.,Chen Yiyun,Meier Stefanie,Daniel Bence,Sandor Katalin,Xu Peng,Huang Jing,Labanieh Louai,Keerthi Vimal,Leruste Amaury,Bashti Malek,Mata-Alcazar Janette,Gkitsas Nikolaos,Guerrero Justin A.,Fisher Chris,Patel Sunny,Asano Kyle,Patel Shabnum,Davis Kara L.,Satpathy Ansuman T.,Feldman Steven A.,Sotillo Elena,Mackall Crystal L.

Publisher

Elsevier BV

Reference72 articles.

1. Targeting immunosuppressive adenosine in cancer;Vijayan,2017

2. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T Cells;Mandapathil;J. Biol. Chem.,2010

3. Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73;Jarvis;Commun. Biol.,2021

4. CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease;Kudryavtsev;Front. Genet.,2019

5. CD73 Is Dispensable for the Regulation of Inflationary CD8+ T-Cells after Murine Cytomegalovirus Infection and Adenovirus Immunisation;Sims;PLoS One,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cancer Treatments through Stem Cell-Derived CAR T Cells for Immunotherapy: Opening New Horizons for the Future of Oncology;Cells;2024-09-10

2. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

3. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

4. The significance of CD8+ tumor-infiltrating lymphocytes exhaustion heterogeneity and its underlying mechanism in diffuse large B-cell lymphoma;International Immunopharmacology;2024-08

5. T cell dysfunction and therapeutic intervention in cancer;Nature Immunology;2024-07-18